日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease

在富含高危疾病的初治慢性淋巴细胞白血病患者人群中开展的阿卡替尼、维奈克拉和奥妥珠单抗的II期研究

Davids, Matthew S; Ryan, Christine E; Lampson, Benjamin L; Ren, Yue; Tyekucheva, Svitlana; Fernandes, Stacey M; Crombie, Jennifer L; Kim, Austin I; Weinstock, Matthew; Montegaard, Josie; Walker, Heather A; Greenman, Claire; Patterson, Victoria; Jacobson, Caron A; LaCasce, Ann S; Armand, Philippe; Fisher, David C; Lo, Steve; Olszewski, Adam J; Arnason, Jon E; Ahn, Inhye E; Brown, Jennifer R

BCL-2 dependence is a favorable predictive marker of response to therapy for chronic lymphocytic leukemia

BCL-2依赖性是慢性淋巴细胞白血病治疗反应的有利预测指标。

Chong, Stephen Jun Fei; Lu, Junyan; Valentin, Rebecca; Lehmberg, Timothy Z; Eu, Jie Qing; Wang, Jing; Zhu, Fen; Kong, Li Ren; Fernandes, Stacey M; Zhang, Jeremy; Herbaux, Charles; Goh, Boon Cher; Brown, Jennifer R; Niemann, Carsten U; Huber, Wolfgang; Zenz, Thorsten; Davids, Matthew S

Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies

新型PI3Kδ抑制剂roginolisib与venetoclax在血液系统恶性肿瘤中具有协同作用

Sasi, Binu Kandathilparambil; Tarantelli, Chiara; Martindale, Stephen; Civanelli, Elisa; Cannas, Eleonora; Sartori, Giulio; Arribas, Alberto J; Fernandes, Stacey M; Shupe, Samantha J; Machado, John-Hanson; Tyekucheva, Svitlana; Ren, Yue; Lahn, Michael; Van der Veen, Lars; Di Conza, Giusy; Bertoni, Francesco; Brown, Jennifer R

Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia

双重难治性和双重暴露慢性淋巴细胞白血病患者的特征和预后

Yoon, James T; Zhou, Yinglu; Mikhaleva, Mariia; Choi, Daniel S; Fernandes, Stacey M; Armand, Philippe; Bessnow, Amy C; Crombie, Jennifer L; Fisher, David C; Jacobsen, Eric D; Jacobson, Caron A; Kim, Austin I; LaCasce, Ann S; Merryman, Reid W; Odejide, Oreofe O; Parry, Erin M; Qualls, David A; Ryan, Christine E; Sekar, Aswin; Soumerai, Jacob D; Arnason, Jon; Tyekucheva, Svitlana; Davids, Matthew S; Brown, Jennifer R; Ahn, Inhye E

FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemia.

FoxO1/Rictor轴通过Akt激活诱导慢性淋巴细胞白血病对伊布替尼产生非遗传适应

Ondrisova Laura, Seda Vaclav, Hlavac Krystof, Pavelkova Petra, Hoferkova Eva, Chiodin Giorgia, Kostalova Lenka, Mladonicka Pavlasova Gabriela, Filip Daniel, Vecera Josef, Zeni Pedro Faria, Oppelt Jan, Kahounova Zuzana, Vichova Rachel, Soucek Karel, Panovska Anna, Plevova Karla, Pospisilova Sarka, Simkovic Martin, Vrbacky Filip, Lysak Daniel, Fernandes Stacey M, Davids Matthew S, Maiques-Diaz Alba, Charalampopoulou Stella, Martin-Subero Jose I, Brown Jennifer R, Doubek Michael, Forconi Francesco, Mayer Jiri, Mraz Marek

Myeloid clonal hematopoiesis of indeterminate potential in patients with chronic lymphocytic leukemia

慢性淋巴细胞白血病患者的髓系克隆性造血功能未定

Vijenthira, Abi; Volpe, Virginia O; Sekar, Aswin; Santos Azevedo, Roberta; Mikhaleva, Mariia; Gibson, Christopher J; Martindale, Stephen P; Fardoun, Rayan; Tyekucheva, Svitlana; Ren, Yue; Fernandes, Stacey M; Knisbacher, Binyamin A; Hahn, Cynthia K; Getz, Gad; Wu, Catherine J; Davids, Matthew S; Brown, Jennifer R

Assaying and classifying T cell function by cell morphology

通过细胞形态学检测和分类T细胞功能

Wang, Xin; Fernandes, Stacey M; Brown, Jennifer R; Kam, Lance C

Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples

通过对慢性淋巴细胞白血病(CLL)患者样本进行全外显子组测序,鉴定出与维奈托克耐药相关的遗传事件

Khalsa, Jasneet Kaur; Cha, Justin; Utro, Filippo; Naeem, Aishath; Murali, Ishwarya; Kuang, Yanan; Vasquez, Kevin; Li, Liang; Tyekucheva, Svitlana; Fernandes, Stacey M; Veronese, Lauren; Guieze, Romain; Sasi, Binu Kandathilparambil; Wang, Zixu; Machado, John-Hanson; Bai, Harrison; Alasfour, Maryam; Rhrissorrakrai, Kahn; Levovitz, Chaya; Danysh, Brian P; Slowik, Kara; Jacobs, Raquel A; Davids, Matthew S; Paweletz, Cloud P; Leshchiner, Ignaty; Parida, Laxmi; Getz, Gad; Brown, Jennifer R

Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance

Pirtobrutinib靶向治疗对伊布替尼耐药的慢性淋巴细胞白血病(CLL)中的BTK C481S突变,但第二位点的BTK突变会导致耐药。

Naeem, Aishath; Utro, Filippo; Wang, Qing; Cha, Justin; Vihinen, Mauno; Martindale, Stephen; Zhou, Yinglu; Ren, Yue; Tyekucheva, Svitlana; Kim, Annette S; Fernandes, Stacey M; Saksena, Gordon; Rhrissorrakrai, Kahn; Levovitz, Chaya; Danysh, Brian P; Slowik, Kara; Jacobs, Raquel A; Davids, Matthew S; Lederer, James A; Zain, Rula; Smith, C I Edvard; Leshchiner, Ignaty; Parida, Laxmi; Getz, Gad; Brown, Jennifer R

Molecular map of chronic lymphocytic leukemia and its impact on outcome

慢性淋巴细胞白血病的分子图谱及其对预后的影响

Knisbacher, Binyamin A; Lin, Ziao; Hahn, Cynthia K; Nadeu, Ferran; Duran-Ferrer, Martí; Stevenson, Kristen E; Tausch, Eugen; Delgado, Julio; Barbera-Mourelle, Alex; Taylor-Weiner, Amaro; Bousquets-Muñoz, Pablo; Diaz-Navarro, Ander; Dunford, Andrew; Anand, Shankara; Kretzmer, Helene; Gutierrez-Abril, Jesus; López-Tamargo, Sara; Fernandes, Stacey M; Sun, Clare; Sivina, Mariela; Rassenti, Laura Z; Schneider, Christof; Li, Shuqiang; Parida, Laxmi; Meissner, Alexander; Aguet, François; Burger, Jan A; Wiestner, Adrian; Kipps, Thomas J; Brown, Jennifer R; Hallek, Michael; Stewart, Chip; Neuberg, Donna S; Martín-Subero, José I; Puente, Xose S; Stilgenbauer, Stephan; Wu, Catherine J; Campo, Elias; Getz, Gad